The FDA has granted Fast Track designation to VS-041, an investigational therapy for the treatment of heart failure with preserved ejection fraction.
Medically reviewed by Christopher Lee, MD Key Takeaways ATTR-CM is a rare, underdiagnosed contributor to heart failure.There ...
Heart attack, a sudden blockage of blood flow to the heart muscle, differs from chronic cardiac failure, where the heart weakens and struggles to pump blood effectively. While a heart attack is an ...
Thanksgiving is a time for family, food, and tradition, but doctors say the holiday season is also one of the most dangerous ...
Cardiovascular mortality declined across 9 high-income nations, but heart failure mortality reductions lagged.